BON Announces Reciept of Nasdaq Compliance Letter

BON Launches AI-Powered New Drug Research and Development

BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd

BON Announces Nasdaq Compliance

Bon Announces Breakthrough Order for $16 Million Gut-Health Products

Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.

BON Announces Share Repurchase Program for up to US$1.0 Million

BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade

BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement

Bon Natural Life Limited Announces Effectiveness of Reverse Stock Split